Concord Healthcare Group Co., Ltd., a joint stock company incorporated in the People's Republic of China, has announced the placement of new shares under a general mandate. The company's H shares are listed on the Main Board of the Stock Exchange with the stock code 2453. The placement will be completed in accordance with the terms and conditions set out in the Placing Agreement. The process is coordinated by a sole overall coordinator, placing agent, and capital market intermediary. The completion date for the placement is expected to be the second business day after the granting of the Listing Approval, with a final deadline by 5 June 2025.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。